Tuesday, 02 January 2024 12:17 GMT

Inspiremd To Participate In Upcoming H.C. Wainwright 28Th Annual Global Investment Conference


(MENAFN- GlobeNewsWire - Nasdaq) MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the“Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14th at 2:30 pm Eastern Time (ET).

A live audio webcast and an archive of the recording will be available through the investors page of InspireMD's corporate website at .

To request a meeting or for more details about the conferences, please reach out to your institutional contact.

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNetTM mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD's common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company's website. For more information, please visit

Investor Contacts:
Jeff Warren
LifeSci Advisors
...
...


MENAFN03092026004107003653ID1111617314



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story